Description: This will be an interactive Grand Rounds session to explore the evolving treatment landscape for Hodgkin lymphoma, highlighting key 2025 guideline updates. Presented in a clinical debate format, the goal will be to examine the evidence, benefits, and limitations of chemotherapy versus immune checkpoint inhibitor-based therapy. After the presentation, the audience will gain insight into optimal patient selection, sequencing strategies, and future directions in care. 

Microsoft Teams Meeting link to join the live session: Register Here

Speaker: Karen Hoff, PharmD, PGY2 Oncology Pharmacy Resident - Atrium Health Wake Forest Baptist Medical Center and Megan Wolff, PharmD, PGY2 Oncology Pharmacy Resident – Atrium Health Wake Forest Baptist Medical Center  

Objectives: ​​ 

  • Recall current NCCN 2025 guideline updates regarding immune checkpoint inhibitors in first-line and relapsed classical Hodgkin lymphoma 

  • Outline efficacy, response rates, and toxicity profiles of PD-1–based regimens versus traditional chemotherapy in Hodgkin lymphoma 

  • Interpret clinical trial evidence to inform individualized patient treatment choices 

  • Select guideline-recommended strategies for real-world cases via clinical debate and audience response 

Target Audience:​ Advocate Pharmacists, Physicians, Nurses, and other interested healthcare professionals

Disclosure:​ The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose.

Activity Flyer: File Single Activity Flyer - KHoff and MWolff.docx 

PDF icon KHoff & MWolff_Lymphoma CE Audience.pdf

Session date: 
10/16/2025 - 12:00pm to 1:00pm CDT
Location: 
Atrium Wake Forest Reynolds Tower Penthouse or Virtual via Teams
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
    Attendance Credit
    • 1.00 Approved AMA PRA Category 1 Credit™
  • 1.00 Continuing Nursing Education (CE)
    Aurora Health Care is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 1.00 contact hours have been awarded to this activity by the Wisconsin Nursing Association. To receive contact hours, participants must attend the entire activity.
    • 1.00 APRN Pharmacotherapeutic Contact Hours
  • 1.00 Continuing Pharmacy Education (CPE)
    Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Please login or register to take this course.